Announced Fri, 8 May · 18:09 IST

Elevation of Mr. Ankur Kharbanda (currently designated as Executive Director and CBO), as Executive Director and Deputy Chief Executive Officer effective May 08, 2026.

Multiple Ind Directors ResignedManagement Changes View source PDF

NIVABUPA · price

Loading chart…

▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.

Price reaction · full curve 14 horizons · vs prior close
+2.8%1-day move
₹81.29
prior close
₹84.40
base price
After-mkt
timing
5m10m15m30m1D2D3D4D5D7D15D1M2M3M
+3.8+4.9+3.8+3.7+2.8+1.5-1.4-1.6-1.6+0.4+3.3+1.7+8.4
Up moveDown movePending
AI summary

Niva Bupa's Board meeting on May 8, 2026 announced multiple changes. Two Non-Executive Directors - Ms. Penelope Ruth Dudley and Mr. Carlos Antonio Jaureguizar Ruiz-Jarabo - resigned citing insufficient time due to other professional commitments. They were replaced by Mr. Christopher Patrick Carroll (CEO of Bupa Global, India & UK) and Ms. Siobhan Djihan Moynihan (CFO of Bupa Global, India & UK) as Additional Non-Executive Directors effective May 15, 2026. Mr. Ankur Kharbanda was elevated from Executive Director and CBO to Executive Director and Deputy CEO. Additionally, the company granted 12,251,268 ESOPs to eligible employees at ₹72.45 per option under the ESOP Scheme 2024.

Likely market impact

The simultaneous resignation of two foreign national directors (both citing time constraints) and their replacement with senior Bupa Group executives suggests closer integration with the parent company. The ESOP grant of over 12 million options is a significant employee retention initiative.